April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Fcrn Expression in the Human Retinal Pigment Epithelium
Author Affiliations & Notes
  • K. van Bilsen
    Internal Department/Clinical Immunology,
    Erasmus MC, Rotterdam, The Netherlands
  • P. M. van Hagen
    Internal Department/Clinical Immunology,
    Erasmus MC, Rotterdam, The Netherlands
    The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • J. Bastiaans
    Immunology,
    Erasmus MC, Rotterdam, The Netherlands
  • J. van Meurs
    The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • G. S. Baarsma
    The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • T. Missotten
    The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • R. W. Kuijpers
    Ophthalmology,
    Erasmus MC, Rotterdam, The Netherlands
  • H. Hooijkaas
    Immunology,
    Erasmus MC, Rotterdam, The Netherlands
  • G. M. Dingjan
    Immunology,
    Erasmus MC, Rotterdam, The Netherlands
  • W. A. Dik
    Immunology,
    Erasmus MC, Rotterdam, The Netherlands
  • Footnotes
    Commercial Relationships  K. van Bilsen, None; P.M. van Hagen, None; J. Bastiaans, None; J. van Meurs, None; G.S. Baarsma, None; T. Missotten, None; R.W. Kuijpers, None; H. Hooijkaas, None; G.M. Dingjan, None; W.A. Dik, None.
  • Footnotes
    Support  SWOO grant
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 840. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. van Bilsen, P. M. van Hagen, J. Bastiaans, J. van Meurs, G. S. Baarsma, T. Missotten, R. W. Kuijpers, H. Hooijkaas, G. M. Dingjan, W. A. Dik; Fcrn Expression in the Human Retinal Pigment Epithelium. Invest. Ophthalmol. Vis. Sci. 2010;51(13):840.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The neonatal Fc receptor (FcRn) protects immunoglobulin G (IgG) from catabolism and controls IgG transport between different cell layers. The FcRn extends the serum half-life of IgG by returning pinocytosed IgG back to the cell surface of vascular endothelial cells and into the bloodstream. IgG can also be found in the vitreous of the eye. How IgG is processed in or transported out of the vitreous is currently unknown, but the FcRn is a candidate molecule to regulate these processes. However, data on FcRn expression in the human eye are lacking. The main objective of this study was to examine FcRn expression in human retinal pigment epithelium (RPE) cells.

Methods: : RPE cell cultures were established from three donor eyes (harvested for cornea transplantation). In these RPE cultures and in human ARPE-19 cells FcRn and beta-2-microglobulin (β2M) mRNA levels were determined by real time quantitative PCR (RQ-PCR). FcRn protein expression was analysed by immunoprecipitation studies. Stimulation assays were performed with human TNF-alpha and recombinant human IFN-gamma. HT-29 and THP-1 cell lines were used as positive controls, HeLa cell line was used as negative control.

Results: : RQ-PCR revealed expression of FcRn mRNA in all three RPE cultures. FcRn mRNA was co-expressed with β2M mRNA. Western Blot analysis, using two different FcRn antibodies, demonstrated that the FcRn mRNA expression in all three RPE cultures co-existed with FcRn protein expression. FcRn expression in RPE cells is downregulated after stimulation with TNF-alpha and IFN-gamma, whereas FcRn expression in HT-29 and THP-1 cells is upregulated after stimulation with those cytokines.

Conclusions: : Human RPE cells express the FcRn. Proinflammatory cytokine TNF-alpha downregulates FcRn expression. We speculate that the FcRn may play a pivotal role in the immune privilege of the human eye.

Keywords: immune tolerance/privilege • retinal pigment epithelium • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×